-
September 29: The Week in Cancer News
Cancer drug shortages affect pediatric care, and ‘power dynamics’ limit women’s access to cancer care globally.
by Kevin McLaughlin
-
September 22: The Week in Cancer News
Study links proper dental hygiene to increased survival in head and neck cancer, and researchers use breast milk to detect breast cancer in new mothers.
by Thomas Celona
-
September 15: The Week in Cancer News
New report charts progress in cancer care, and immediate access to test results can lead to confusion.
by Eric Fitzsimmons
-
September 8: The Week in Cancer News
Research shows an increase in late-stage prostate cancer diagnosis, and many non-English speakers don’t make it past helplines to access services.
by Marci A. Landsmann
-
September 1: The Week in Cancer News
Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and a cancer drug is among 10 selected for price negotiations with Medicare to lower costs.
by Kevin McLaughlin
-
August 25: The Week in Cancer News
Study finds association between lorazepam use and poorer cancer outcomes, and weight-loss surgery linked to lower cancer risk in women.
by Thomas Celona
-
August 18: The Week in Cancer News
Radiation therapy is falling out of favor for some cancer types, and concerns grow about commercially available multi-cancer detection tests.
by Eric Fitzsimmons
-
August 11: The Week in Cancer News
Research links testicular cancer in military firefighters to ‘forever chemicals,’ and older women who are screened for breast cancer at risk for overdiagnosis.
by Marci A. Landsmann
-
August 4: The Week in Cancer News
Genetic testing can help establish inherited cancer risk, and a new cancer registry tracks breast and prostate cancer in people of African origin.
by Kevin McLaughlin
-
July 28: The Week in Cancer News
Less than four minutes of physical activity per day linked to lower cancer risk, and vaccination helped improve outcomes for cancer patients with COVID-19.
by Thomas Celona
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore